|
ETAA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.139000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.296400E-02 |
| Normal-vs-Stage2 |
1.147800E-01 |
| Normal-vs-Stage3 |
1.814200E-01 |
| Normal-vs-Stage4 |
4.812400E-01 |
| Stage1-vs-Stage2 |
3.286800E-01 |
| Stage1-vs-Stage3 |
9.588600E-01 |
| Stage1-vs-Stage4 |
7.830200E-01 |
| Stage2-vs-Stage3 |
4.606600E-01 |
| Stage2-vs-Stage4 |
8.483200E-01 |
| Stage3-vs-Stage4 |
8.036200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.499000E-03 |
| Normal-vs-AfricanAmerican |
8.104500E-02 |
| Normal-vs-Asian |
7.618800E-01 |
| Caucasian-vs-AfricanAmerican |
8.309200E-01 |
| Caucasian-vs-Asian |
6.971400E-01 |
| AfricanAmerican-vs-Asian |
7.565600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.836000E-02 |
| Normal-vs-Female |
4.598800E-04 |
| Male-vs-Female |
2.571900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.884400E-01 |
| Normal-vs-Extreme_Weight |
4.686800E-01 |
| Normal-vs-Obese |
8.720000E-03 |
| Normal-vs-Extreme_Obese |
3.886800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.048400E-01 |
| Normal_Weight-vs-Obese |
4.380600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.160600E-01 |
| Extreme_Weight-vs-Obese |
5.060100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.241800E-01 |
| Obese-vs-Extreme_Obese |
7.180400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.573680E-02 |
| Normal-vs-Age(41-60Yrs) |
7.361500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.184840E-01 |
| Normal-vs-Age(81-100Yrs) |
9.952000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.370000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.353810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.325500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.874500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.369210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.611000E-04 |
| Normal-VS-Type2 PRCC |
7.269400E-01 |
| Normal-VS-KIRP CIMP |
1.211540E-02 |
| Normal-VS-Unclassified PRCC |
4.073900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.622800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.333550E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.059400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.160200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.219900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.330800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.941800E-01 |
| Normal-vs-N1 |
3.735500E-02 |
| Normal-vs-N2 |
6.500800E-01 |
| N0-vs-N1 |
2.235800E-02 |
| N0-vs-N2 |
9.060600E-01 |
| N1-vs-N2 |
2.709800E-01 |
|
|
